Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 15 NVO Novo Nordisk Weigh-Loss Drugs Could Bankrupt US Health Care, Senate Committee Report Says
May 15 NVO No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms
May 15 NVO Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
May 15 NVO Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
May 15 NVO If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today
May 15 NVO Novo Nordisk owner to acquire major stake in Austrian life sciences firm
May 15 RNA Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors
May 15 ADMA 5 Stocks With Recent Price Strength to Tap May's Rally
May 15 NVO Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
May 15 NVO Novo Nordisk Bets Up to $600 Million on Ozempic 2.0. Here's Why the Stock Is a Buy.
May 15 NVO PRESS DIGEST- Financial Times - May 15
May 14 NVO Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
May 14 NVO Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
May 14 NVO Novo Nordisk to test obesity drugs including Wegovy in alcohol use
May 14 REGN Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
May 14 NVO European Equities Close Mostly Higher in Tuesday Trading; Anglo American Plans Overhaul in Face of BHP Takeover Bid
May 14 NVO Novo Nordisk's Wegovy Reduces Cardiac Events, Sustains Weight Loss, New Analysis Shows
May 14 REGN Evercore says biotech ‘winter is finally thawing’
May 14 NVO Ozempic Maker Novo Sells $5 Billion in Bonds to Fund Deal
May 14 NVO Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags